Stroke care during the COVID‐19 pandemic: experience from three large European countries

In order to cope with the exponentially increasing number of patients infected with SARS‐CoV‐2, European countries made enormous efforts to reorganize medical assistance and several diseases, including stroke, were particularly impacted. We report the experience of stroke neurologists from three Eur...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:European journal of neurology Ročník 27; číslo 9; s. 1794 - 1800
Hlavní autori: Bersano, A., Kraemer, M., Touzé, E., Weber, R., Alamowitch, S., Sibon, I., Pantoni, L.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England John Wiley & Sons, Inc 01.09.2020
John Wiley and Sons Inc
Predmet:
care
COVID-19
emergency
Emergency medical care
Emergency medical services
Europe
France
Germany
Hospitals
Humans
Italy
outbreak
Pandemics
pathways
Patients
Review
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Stroke
Stroke - diagnosis
Stroke - mortality
Stroke - therapy
Time dependence
Transient ischemic attack
Viral diseases
Italy
France
Europe
Germany
COVID-19
Europe
emergency
outbreak
pathways
stroke
care
ISSN:1351-5101, 1468-1331, 1468-1331
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:In order to cope with the exponentially increasing number of patients infected with SARS‐CoV‐2, European countries made enormous efforts to reorganize medical assistance and several diseases, including stroke, were particularly impacted. We report the experience of stroke neurologists from three European countries (Italy, France and Germany) that faced the pandemic at diverse time points and with different approaches, depending on their resources and healthcare system organization. Pre‐hospital and in‐hospital acute stroke pathways were reorganized to prioritize COVID‐19 management and, in severely affected regions of Italy and France, stroke care was centralized to a limited number of centers, whereas the remaining stroke units were dedicated to patients with COVID‐19. Access to acute stroke diagnostics and time‐dependent therapies was limited or delayed because of reduced capacities of emergency services due to the burden of patients with COVID‐19. A marked reduction in the number of patients presenting with transient ischaemic attack and stroke was noted in the emergency departments of all three countries. Although we only have preliminary data, these conditions may have affected stroke outcome. These indirect effects of the COVID‐19 pandemic could negate the efforts of stroke neurologists over the last few years to improve outcome and reduce mortality of stroke patients. Although the SARS‐CoV‐2 infection rate is slowing down in Europe, the effects of ending lockdown in the next months are unpredictable. It is important for the European and world stroke community to share what has been learned so far to be plan strategies to ensure stroke care in the future and upcoming challenging times.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1351-5101
1468-1331
1468-1331
DOI:10.1111/ene.14375